These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32728011)

  • 1. Lumateperone (Caplyta) for schizophrenia.
    Med Lett Drugs Ther; 2020 Jul; 62(1603):113-116. PubMed ID: 32728011
    [No Abstract]   [Full Text] [Related]  

  • 2. Lumateperone (Caplyta) for bipolar depression.
    Med Lett Drugs Ther; 2022 Aug; 64(1656):126-128. PubMed ID: 35921078
    [No Abstract]   [Full Text] [Related]  

  • 3. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotic therapy and hyperlipidemia: a review.
    Koro CE; Meyer JM
    Essent Psychopharmacol; 2005; 6(3):148-57. PubMed ID: 15869022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment strategies for schizophrenia.
    Lindenmayer JP; Khan A
    Expert Rev Neurother; 2004 Jul; 4(4):705-23. PubMed ID: 15853589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone.
    Corponi F; Fabbri C; Bitter I; Montgomery S; Vieta E; Kasper S; Pallanti S; Serretti A
    Eur Neuropsychopharmacol; 2019 Sep; 29(9):971-985. PubMed ID: 31255396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan.
    Kishi T; Ikuta T; Sakuma K; Okuya M; Iwata N
    J Psychiatr Res; 2021 Jun; 138():444-452. PubMed ID: 33964682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumateperone: A Novel Antipsychotic for Schizophrenia.
    Greenwood J; Acharya RB; Marcellus V; Rey JA
    Ann Pharmacother; 2021 Jan; 55(1):98-104. PubMed ID: 32590907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of antipsychotic drugs: focus on therapeutic and adverse effects.
    Werner FM; Coveñas R
    Expert Opin Drug Saf; 2014 Aug; 13(8):1031-42. PubMed ID: 24975932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.
    Demyttenaere K; Detraux J; Racagni G; Vansteelandt K
    CNS Drugs; 2019 Jun; 33(6):549-566. PubMed ID: 31065941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.
    Mauri MC; Paletta S; Di Pace C; Reggiori A; Cirnigliaro G; Valli I; Altamura AC
    Clin Pharmacokinet; 2018 Dec; 57(12):1493-1528. PubMed ID: 29915922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.
    Melnik T; Soares BG; Puga ME; Atallah AN
    Sao Paulo Med J; 2010 May; 128(3):141-66. PubMed ID: 20963366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole versus other atypical antipsychotics for schizophrenia.
    Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
    Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.
    Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R
    J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):191-202. PubMed ID: 28219485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.